Annual CAPEX:
$22.67M-$118.80M(-83.98%)Summary
- As of today, ARWR annual capital expenditures is $22.67 million, with the most recent change of -$118.80 million (-83.98%) on September 30, 2025.
- During the last 3 years, ARWR annual CAPEX has fallen by -$30.11 million (-57.05%).
- ARWR annual CAPEX is now -87.18% below its all-time high of $176.74 million, reached on September 30, 2023.
Performance
ARWR CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CAPEX:
$7.49M+$5.13M(+216.79%)Summary
- As of today, ARWR quarterly capital expenditures is $7.49 million, with the most recent change of +$5.13 million (+216.79%) on September 1, 2025.
- Over the past year, ARWR quarterly CAPEX has dropped by -$16.80 million (-69.17%).
- ARWR quarterly CAPEX is now -89.09% below its all-time high of $68.66 million, reached on December 31, 2023.
Performance
ARWR Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$22.67M-$16.80M(-42.57%)Summary
- As of today, ARWR TTM capital expenditures is $22.67 million, with the most recent change of -$16.80 million (-42.57%) on September 1, 2025.
- Over the past year, ARWR TTM CAPEX has dropped by -$118.80 million (-83.98%).
- ARWR TTM CAPEX is now -89.37% below its all-time high of $213.24 million, reached on March 31, 2024.
Performance
ARWR TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ARWR CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -84.0% | -69.2% | -84.0% |
| 3Y3 Years | -57.0% | -77.1% | -57.0% |
| 5Y5 Years | +89.7% | +297.4% | +89.7% |
ARWR CAPEX Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -87.2% | at low | -89.1% | +216.8% | -89.4% | at low |
| 5Y | 5-Year | -87.2% | +89.7% | -89.1% | +297.4% | -89.4% | +90.4% |
| All-Time | All-Time | -87.2% | >+9999.0% | -89.1% | >+9999.0% | -89.4% | >+9999.0% |
ARWR CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | $22.67M(-84.0%) | - | - |
| Sep 2025 | - | $7.49M(+216.8%) | $22.67M(-42.6%) |
| Jun 2025 | - | $2.36M(-55.4%) | $39.47M(-23.4%) |
| Mar 2025 | - | $5.30M(-29.5%) | $51.55M(-35.8%) |
| Dec 2024 | - | $7.52M(-69.1%) | $80.33M(-43.2%) |
| Sep 2024 | $141.47M(-20.0%) | $24.29M(+68.1%) | $141.47M(-21.9%) |
| Jun 2024 | - | $14.45M(-57.6%) | $181.09M(-15.1%) |
| Mar 2024 | - | $34.08M(-50.4%) | $213.24M(+3.3%) |
| Dec 2023 | - | $68.66M(+7.4%) | $206.48M(+16.8%) |
| Sep 2023 | $176.74M(+234.9%) | $63.91M(+37.1%) | $176.74M(+21.4%) |
| Jun 2023 | - | $46.60M(+70.6%) | $145.54M(+34.2%) |
| Mar 2023 | - | $27.31M(-29.8%) | $108.47M(+26.3%) |
| Dec 2022 | - | $38.91M(+19.0%) | $85.91M(+62.8%) |
| Sep 2022 | $52.78M(+123.9%) | $32.71M(+243.0%) | $52.78M(+86.7%) |
| Jun 2022 | - | $9.54M(+100.7%) | $28.27M(+24.7%) |
| Mar 2022 | - | $4.75M(-17.8%) | $22.66M(-9.6%) |
| Dec 2021 | - | $5.78M(-29.5%) | $25.07M(+6.4%) |
| Sep 2021 | $23.57M(+97.2%) | $8.20M(+108.6%) | $23.57M(+36.6%) |
| Jun 2021 | - | $3.93M(-45.1%) | $17.25M(+11.6%) |
| Mar 2021 | - | $7.17M(+67.8%) | $15.46M(+29.9%) |
| Dec 2020 | - | $4.27M(+126.7%) | $11.90M(-0.4%) |
| Sep 2020 | $11.95M(-0.4%) | $1.88M(-11.9%) | $11.95M(-33.2%) |
| Jun 2020 | - | $2.14M(-40.8%) | $17.90M(-5.7%) |
| Mar 2020 | - | $3.61M(-16.4%) | $18.98M(+21.8%) |
| Dec 2019 | - | $4.32M(-44.8%) | $15.58M(+29.8%) |
| Sep 2019 | $12.00M(+744.4%) | $7.83M(+142.9%) | $12.00M(+145.9%) |
| Jun 2019 | - | $3.22M(+1440.1%) | $4.88M(+163.1%) |
| Mar 2019 | - | $209.30K(-71.6%) | $1.85M(-8.4%) |
| Dec 2018 | - | $737.50K(+3.9%) | $2.02M(+42.4%) |
| Sep 2018 | $1.42M(-82.1%) | $709.50K(+258.2%) | $1.42M(+73.5%) |
| Jun 2018 | - | $198.10K(-47.6%) | $819.20K(-53.9%) |
| Mar 2018 | - | $378.30K(+179.4%) | $1.78M(-35.5%) |
| Dec 2017 | - | $135.40K(+26.1%) | $2.76M(-65.2%) |
| Sep 2017 | $7.92M(+105.1%) | $107.40K(-90.7%) | $7.92M(-24.8%) |
| Jun 2017 | - | $1.16M(-14.7%) | $10.52M(+5.1%) |
| Mar 2017 | - | $1.36M(-74.4%) | $10.01M(+14.4%) |
| Dec 2016 | - | $5.30M(+95.3%) | $8.75M(+126.7%) |
| Sep 2016 | $3.86M(+95.9%) | $2.71M(+319.2%) | $3.86M(+94.7%) |
| Jun 2016 | - | $647.10K(+588.4%) | $1.98M(+22.4%) |
| Mar 2016 | - | $94.00K(-76.9%) | $1.62M(-11.1%) |
| Dec 2015 | - | $406.60K(-51.3%) | $1.82M(-7.5%) |
| Sep 2015 | $1.97M(+14.7%) | $835.00K(+194.4%) | $1.97M(+23.1%) |
| Jun 2015 | - | $283.60K(-4.5%) | $1.60M(-18.4%) |
| Mar 2015 | - | $297.10K(-46.5%) | $1.96M(-9.0%) |
| Dec 2014 | - | $554.90K(+19.2%) | $2.16M(+25.5%) |
| Sep 2014 | $1.72M(+478.4%) | $465.40K(-27.8%) | $1.72M(+26.5%) |
| Jun 2014 | - | $644.20K(+31.0%) | $1.36M(+55.4%) |
| Mar 2014 | - | $491.60K(+323.1%) | $873.20K(+116.4%) |
| Dec 2013 | - | $116.20K(+10.5%) | $403.60K(+36.0%) |
| Sep 2013 | $296.90K(-38.1%) | $105.20K(-34.3%) | $296.80K(+6.6%) |
| Jun 2013 | - | $160.20K(+628.2%) | $278.50K(+19.1%) |
| Mar 2013 | - | $22.00K(+134.0%) | $233.90K(-44.3%) |
| Dec 2012 | - | $9400.00(-89.2%) | $419.70K(-12.5%) |
| Sep 2012 | $479.70K | $86.90K(-24.8%) | $479.70K(+22.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2012 | - | $115.60K(-44.4%) | $392.80K(+39.8%) |
| Mar 2012 | - | $207.80K(+199.4%) | $281.00K(+255.2%) |
| Dec 2011 | - | $69.40K(>+9900.0%) | $79.10K(+715.5%) |
| Sep 2011 | $9700.00(+79.6%) | $0.00(-100.0%) | $9700.00(-35.8%) |
| Jun 2011 | - | $3800.00(-35.6%) | $15.10K(+33.6%) |
| Mar 2011 | - | $5900.00(>+9900.0%) | $11.30K(+109.3%) |
| Dec 2010 | - | $0.00(-100.0%) | $5400.00(0.0%) |
| Sep 2010 | $5400.00(-86.6%) | $5400.00(>+9900.0%) | $5400.00(>+9900.0%) |
| Jun 2010 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2010 | - | $0.00(0.0%) | $12.10K(0.0%) |
| Dec 2009 | - | $0.00(0.0%) | $12.10K(-69.9%) |
| Sep 2009 | $40.20K(-94.1%) | $0.00(-100.0%) | $40.20K(-81.3%) |
| Jun 2009 | - | $12.10K(>+9900.0%) | $215.40K(-39.6%) |
| Mar 2009 | - | $0.00(-100.0%) | $356.60K(-34.5%) |
| Dec 2008 | - | $28.10K(-84.0%) | $544.50K(-20.4%) |
| Sep 2008 | $684.10K(-9.6%) | $175.20K(+14.3%) | $684.20K(-2.5%) |
| Jun 2008 | - | $153.30K(-18.4%) | $701.70K(-26.8%) |
| Mar 2008 | - | $187.90K(+12.0%) | $959.00K(+18.6%) |
| Dec 2007 | - | $167.80K(-12.9%) | $808.70K(+6.9%) |
| Sep 2007 | $756.40K(-19.1%) | $192.70K(-53.1%) | $756.50K(-13.3%) |
| Jun 2007 | - | $410.60K(+992.0%) | $872.50K(+27.4%) |
| Mar 2007 | - | $37.60K(-67.5%) | $685.00K(-8.5%) |
| Dec 2006 | - | $115.60K(-62.6%) | $748.50K(+2.6%) |
| Sep 2006 | $934.50K(+21.2%) | $308.70K(+38.4%) | $729.50K(+59.5%) |
| Jun 2006 | - | $223.10K(+120.7%) | $457.50K(-3.2%) |
| Mar 2006 | - | $101.10K(+4.7%) | $472.80K(+1.8%) |
| Dec 2005 | - | $96.60K(+163.2%) | $464.50K(-37.7%) |
| Sep 2005 | $771.10K(+15.9%) | $36.70K(-84.6%) | $746.10K(-35.3%) |
| Jun 2005 | - | $238.40K(+156.9%) | $1.15M(+2.2%) |
| Mar 2005 | - | $92.80K(-75.5%) | $1.13M(+8.1%) |
| Dec 2004 | - | $378.20K(-14.8%) | $1.04M(+56.8%) |
| Sep 2004 | $665.50K(>+9900.0%) | $443.90K(+107.9%) | $665.50K(+197.5%) |
| Jun 2004 | - | $213.50K(+2535.8%) | $223.70K(+2093.1%) |
| Mar 2004 | - | $8100.00(>+9900.0%) | $10.20K(+385.7%) |
| Dec 2003 | - | $0.00(-100.0%) | $2100.00(0.0%) |
| Sep 2003 | $2100.00(+23.5%) | $2100.00(>+9900.0%) | $2100.00(>+9900.0%) |
| Jun 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2002 | - | $0.00(0.0%) | $1700.00(0.0%) |
| Sep 2002 | $1700.00(>+9900.0%) | $0.00(0.0%) | $1700.00(0.0%) |
| Jun 2002 | - | $0.00(-100.0%) | $1700.00(0.0%) |
| Mar 2002 | - | $1700.00(>+9900.0%) | $1700.00(>+9900.0%) |
| Dec 2001 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2001 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2001 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2001 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2000 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2000 | $700.00(>+9900.0%) | $0.00(0.0%) | $700.00(0.0%) |
| Jun 2000 | - | $0.00(0.0%) | $700.00(0.0%) |
| Mar 2000 | - | $0.00(-100.0%) | $700.00(0.0%) |
| Dec 1999 | - | $700.00(>+9900.0%) | $700.00(>+9900.0%) |
| Sep 1999 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Jun 1999 | - | $0.00 | $0.00 |
| Sep 1998 | $0.00 | - | - |
FAQ
- What is Arrowhead Pharmaceuticals, Inc. annual capital expenditures?
- What is the all-time high annual CAPEX for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. annual CAPEX year-on-year change?
- What is Arrowhead Pharmaceuticals, Inc. quarterly capital expenditures?
- What is the all-time high quarterly CAPEX for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. quarterly CAPEX year-on-year change?
- What is Arrowhead Pharmaceuticals, Inc. TTM capital expenditures?
- What is the all-time high TTM CAPEX for Arrowhead Pharmaceuticals, Inc.?
- What is Arrowhead Pharmaceuticals, Inc. TTM CAPEX year-on-year change?
What is Arrowhead Pharmaceuticals, Inc. annual capital expenditures?
The current annual CAPEX of ARWR is $22.67M
What is the all-time high annual CAPEX for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high annual capital expenditures is $176.74M
What is Arrowhead Pharmaceuticals, Inc. annual CAPEX year-on-year change?
Over the past year, ARWR annual capital expenditures has changed by -$118.80M (-83.98%)
What is Arrowhead Pharmaceuticals, Inc. quarterly capital expenditures?
The current quarterly CAPEX of ARWR is $7.49M
What is the all-time high quarterly CAPEX for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high quarterly capital expenditures is $68.66M
What is Arrowhead Pharmaceuticals, Inc. quarterly CAPEX year-on-year change?
Over the past year, ARWR quarterly capital expenditures has changed by -$16.80M (-69.17%)
What is Arrowhead Pharmaceuticals, Inc. TTM capital expenditures?
The current TTM CAPEX of ARWR is $22.67M
What is the all-time high TTM CAPEX for Arrowhead Pharmaceuticals, Inc.?
Arrowhead Pharmaceuticals, Inc. all-time high TTM capital expenditures is $213.24M
What is Arrowhead Pharmaceuticals, Inc. TTM CAPEX year-on-year change?
Over the past year, ARWR TTM capital expenditures has changed by -$118.80M (-83.98%)